However, we found that pediatric AML patients with higher fraction of IgA1 (Fig. 4c) and adult AML patients with higher fraction of IgA2 (Fig. 4d) have significantly worse overall survival (Additional file 2: Figure S8). The gene discussed is IGHA1; the disease is acute myeloid leukemia.